MUMBAI, India, Feb. 6 -- Intellectual Property India has published a patent application (202541121507 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Dec. 4, 2025, for 'composition of 1,2,3-selenadiazole containing compounds with pharmacological properties.'
Inventor(s) include Dr. K Kalpana; Dr. M. Murphy; and Dr Ramya Mohan.
The application for the patent was published on Feb. 6, under issue no. 06/2026.
According to the abstract released by the Intellectual Property India: "A system designed to deliver live events with minimal delay, this solution utilizes innovative techniques to optimize the entire transmission process. By employing adaptive encoding, parallel data streaming, and edge computing, the system effectively reduces latency and ensures a seamless viewing experience for the audience. Adaptive encoding dynamically adjusts the video quality based on network conditions, optimizing bandwidth usage and minimizing buffering. Parallel data streaming divides the video into multiple streams, allowing for more efficient delivery and reducing the impact of network congestion. Edge computing brings processing power closer to the end-user, decreasing transmission distances and latency. Furthermore, the system incoiporates predictive network analytics to select optimal transmission paths, avoiding network bottlenecks and ensuring smooth delivery. Advanced error correction mechanisms safeguard data integrity, preventing disruptions and maintaining the quality of the live broadcast. These combined technologies enable the system to deliver high-quality, low-latency live streams across various networks and devices, providing a superior viewing experience for audiences worldwide."
Disclaimer: Curated by HT Syndication.
